Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Norbert W. Bischofberger, PhD
Age : 62
Public asset : 164,646,328 USD
Linked companies : Bayer AG
Dr. Norbert W. Bischofberger is a Chief Executive Officer at Kronos Bio, Inc.

He is on the Board of Directors at Bayer AG and InCarda Therapeutics, Inc. Dr. Bischofberger was previously employed as a CSO, Executive VP-Research & Development by Gilead Sciences, Inc. and a Senior Scientist-DNA Synthesis Group by Genentech, Inc.

He received his undergraduate degree from the University of Innsbruck and a doctorate degree from Swiss Federal Institute of Technology.

Current positions of Norbert W. Bischofberger, PhD 
NameTitle Since
Bayer AG
Member-Supervisory Board 2017
Kronos Bio, Inc. Chief Executive Officer 2018
InCarda Therapeutics, Inc. Director 2016

Holdings of Norbert W. Bischofberger, PhD 
Gilead Sciences (GILD)
Biotechnology & Medical Research
2,324,2000.18%164,646,328 USD

Norbert W. Bischofberger, PhD: Personal Network 

Most Read News 
07/17ELON MUSK : Tesla shares fall after CEO Musk abuses British caver
07/20DANIEL LOEB : Japan firms tap banks for advice as activists circle
07/18JAMES GORMAN : Morgan Stanley boss Gorman hits out at Fed stress tests
07/19MASAYOSHI SON : SoftBank's Son says Japan is 'stupid' to disallow ride-sharing
07/21SERGIO MARCHIONNE : Fiat Chrysler names Jeep boss to replace stricken CEO Marchionne
07/19JOHN BROWN : General Electric's power unit faces threat in Saudi Arabia
07/16WARREN BUFFETT : Warren Buffett donates $3.4 billion to Gates' and family charities
07/16ULRICH LEHNER : Thyssenkrupp in leadership turmoil as chairman quits
07/15ANTTI HERLIN : Thyssen and Kone owners held merger talks on elevator ops
07/18WARREN BUFFETT : Buffett's Berkshire Hathaway loosens policy on stock buybacks
More news

© 2018 People and Ownership :   
Norbert W. Bischofberger, PhD : Connections 
Institute for Systems Biology
Two River Group Holdings LLC
Two Rivers Consulting Corp.
Cullinan Oncology LLC
Two River Group Management LLC
Desert Flower Foundation GmbH
Riverbank Capital Securities, Inc.
The Wharton School of the University of Pennsylvania
Danube Pharmaceuticals, Inc.

Popular Business Leaders 
Paul Achleitner William Ackman Frank Appel Luc Besson Jeff Bezos Lloyd Blankfein Vincent Bolloré Warren Buffett Patrice Caine Vittorio Colao Tim Cook Serge Dassault Michael Dell Oleg Deripaska Patrick Drahi John Edwards Bill Gates Carlos Ghosn James Gorman David Henry Heinrich Hiesinger Carl Icahn Brian Krzanich Daniel Loeb Jack Ma Sergio Marchionne Laurent Mignon Dennis Muilenburg Rupert Murdoch Elon Musk Xavier Niel Frédéric Oudéa Gavin Patterson Georges Plassat Wolfgang Porsche Sumner Redstone Wilbur Ross Howard Schultz Masayoshi Son George Soros Martin Sorrell Rupert Stadler Tidjane Thiam Peter Thiel Viktor Vekselberg John Williamson Martin Winterkorn Steve Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders